All-cause 30-day hospital readmission rates for Medicare beneficiaries dropped by a full percentage point between 2012 and 2013, a trend the federal government attributes in part to readmission penalties for heart failure, acute MI and pneumonia.

The National Lipid Association (NLA) bumped up timing of draft recommendations for managing patients with dyslipidemia, spurred by the publication of cholesterol guidelines from two cardiology societies. The two sets of guidelines agree about the use of statins but diverge over targets.

Will you be adding Google Glass to your cath lab accoutrements in the future? The Society for Cardiovascular Angiography and Interventions (SCAI) added a session to explore what role Google Glass might play in interventional cardiology.

Some physicians are taking exception with recommendations that call for statin treatment in generally healthy women, saying the clinical trials that guideline writers evaluated did not have sufficient representation of women patients. The story was published May 6 in the New York Times “Wellness” section.

It may be a bitter pill to swallow, but the FDA rejected Bayer’s bid to change the labeling for aspirin to include primary prevention of a first heart attack in some at-risk patients.

One out of every three premature heart disease deaths and stroke deaths could be prevented, according to the Centers for Disease Control and Prevention (CDC). A May 2 report showed that modifying risk factors and other strategies might reduce cardiovascular and cerebrovascular deaths by almost 109,000 annually.

ACE is proud to be invited as a guest speaker at the 10th annual Complex Cardiovascular Catheter Therapeutics: Advanced Endovascular and Coronary Intervention Global Summit (C3), taking place June 23-27, 2014 at the Hilton Bonnet Creek, Orlando, Florida. Sheree Schroeder, MSN, RN, RDCS, FASE,  ACE's Director of Quality Review Services , will be speaking on the topic "No Margin, No Mission" A Team Based Approach for Billing.

A need, a vision, a plan, and a team. That’s how the total vein care program for treatment of CVI started at Cardiovascular Associates of East Texas, a private practice of 11 cardiologists in Tyler.